


Healthcare News Roundup: Oncology
HSMN NewsFeed - 28 Oct 2019
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
HSMN NewsFeed - 22 Oct 2019
Verix Health Raises $8 Million To Advance Steerable Surgical Device Technology
Verix Health Raises $8 Million To Advance Steerable Surgical Device Technology
HSMN NewsFeed - 21 Oct 2019
Accuray Appoints Medtech Veteran Suzanne Winter as Chief Commercial Officer
Accuray Appoints Medtech Veteran Suzanne Winter as Chief Commercial Officer
HSMN NewsFeed - 17 Oct 2019
World-Renowned Cancer Leader Brian Leyland-Jones Named Chairman of NED Biosystems' Scientific Advisory Board
World-Renowned Cancer Leader Brian Leyland-Jones Named Chairman of NED Biosystems' Scientific Advisory Board
HSMN NewsFeed - 7 Oct 2019
ProTom Receives U.S. FDA 510(k) Clearance for Its Radiance 330(R) Single Room Proton Therapy System
ProTom Receives U.S. FDA 510(k) Clearance for Its Radiance 330(R) Single Room Proton Therapy System
HSMN NewsFeed - 26 Sep 2019
RaySearch Expands to a New Major Market With Distribution Agreement for Russia
RaySearch Expands to a New Major Market With Distribution Agreement for Russia
HSMN NewsFeed - 23 Sep 2019
Cologuard(R) Gains FDA Approval For Use In Younger Americans, Ages 45 To 49
Cologuard(R) Gains FDA Approval For Use In Younger Americans, Ages 45 To 49
HSMN NewsFeed - 18 Sep 2019
BioTheryX, Inc. Announces the Appointment of Biopharma Veteran Jeffrey L. Edwards to Board of Directors
BioTheryX, Inc. Announces the Appointment of Biopharma Veteran Jeffrey L. Edwards to Board of Directors
HSMN NewsFeed - 16 Sep 2019
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
HSMN NewsFeed - 12 Sep 2019
I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.
I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.
HSMN NewsFeed - 12 Sep 2019
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
HSMN NewsFeed - 10 Sep 2019
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer
